Antibiotic prescribing for common infections in UK general practice: variability and drivers.


Journal

The Journal of antimicrobial chemotherapy
ISSN: 1460-2091
Titre abrégé: J Antimicrob Chemother
Pays: England
ID NLM: 7513617

Informations de publication

Date de publication:
01 08 2019
Historique:
received: 27 11 2018
revised: 14 03 2019
accepted: 19 03 2019
pubmed: 1 5 2019
medline: 13 8 2020
entrez: 1 5 2019
Statut: ppublish

Résumé

To examine variations across general practices and factors associated with antibiotic prescribing for common infections in UK primary care to identify potential targets for improvement and optimization of prescribing. Oral antibiotic prescribing for common infections was analysed using anonymized UK primary care electronic health records between 2000 and 2015 using the Clinical Practice Research Datalink (CPRD). The rate of prescribing for each condition was observed over time and mean change points were compared with national guideline updates. Any correlation between the rate of prescribing for each infectious condition was estimated within a practice. Predictors of prescribing were estimated using logistic regression in a matched patient cohort (1:1 by age, sex and calendar time). Over 8 million patient records were examined in 587 UK general practices. Practices varied considerably in their propensity to prescribe antibiotics and this variance increased over time. Change points in prescribing did not reflect updates to national guidelines. Prescribing levels within practices were not consistent for different infectious conditions. A history of antibiotic use significantly increased the risk of receiving a subsequent antibiotic (by 22%-48% for patients with three or more antibiotic prescriptions in the past 12 months), as did higher BMI, history of smoking and flu vaccinations. Other drivers for receiving an antibiotic varied considerably for each condition. Large variability in antibiotic prescribing between practices and within practices was observed. Prescribing guidelines alone do not positively influence a change in prescribing, suggesting more targeted interventions are required to optimize antibiotic prescribing in the UK.

Identifiants

pubmed: 31038162
pii: 5481890
doi: 10.1093/jac/dkz163
pmc: PMC6640319
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2440-2450

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.

Références

Formulary. 1995 Oct;30(10):596-8, 601-2, 605
pubmed: 10151723
BMJ. 2003 Jan 18;326(7381):138
pubmed: 12531847
Pharmacoepidemiol Drug Saf. 1999 Jan;8(1):15-21
pubmed: 15073942
Br J Clin Pharmacol. 2004 Nov;58(5):496-502
pubmed: 15521897
J Clin Epidemiol. 2006 Oct;59(10):1087-91
pubmed: 16980149
Qual Saf Health Care. 2007 Apr;16(2):105-9
pubmed: 17403755
Br J Gen Pract. 2009 Oct;59(567):e315-20
pubmed: 19843411
Lancet. 2010 Jan 16;375(9710):248-51
pubmed: 19875163
Enferm Infecc Microbiol Clin. 2011 Mar;29(3):193-200
pubmed: 21345532
Implement Sci. 2013 Jun 21;8:72
pubmed: 23799906
Br J Gen Pract. 2013 Jul;63(612):e429-36
pubmed: 23834879
PLoS One. 2013 Sep 11;8(9):e75131
pubmed: 24040394
J Antimicrob Chemother. 2014 Mar;69(3):835-41
pubmed: 24176983
Ther Adv Drug Saf. 2012 Apr;3(2):89-99
pubmed: 25083228
J Antimicrob Chemother. 2014 Dec;69(12):3423-30
pubmed: 25091508
BMJ Open. 2014 Oct 27;4(10):e006245
pubmed: 25348424
Pain Med. 2015 Apr;16(4):696-705
pubmed: 25521663
BMC Fam Pract. 2015 Jan 29;16:7
pubmed: 25630870
Int J Epidemiol. 2015 Jun;44(3):827-36
pubmed: 26050254
Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:11-20
pubmed: 26152658
BMJ. 2015 Nov 03;351:h5501
pubmed: 26537416
Biomed Res Int. 2015;2015:961526
pubmed: 26539547
J Pediatric Infect Dis Soc. 2015 Dec;4(4):297-304
pubmed: 26582868
Am J Prev Med. 2016 Jun;50(6):692-698
pubmed: 26702478
Eur J Public Health. 2016 Jun;26(3):395-401
pubmed: 26936080
BMC Res Notes. 2017 Jan 13;10(1):41
pubmed: 28086961
Scand J Prim Health Care. 2017 Mar;35(1):10-18
pubmed: 28277045
J Antimicrob Chemother. 2017 Jun 1;72(6):1818-1824
pubmed: 28333200
BMJ. 2017 May 22;357:j2148
pubmed: 28533265
J Epidemiol Community Health. 2017 Sep;71(9):928-936
pubmed: 28790164
Patient Prefer Adherence. 2017 Dec 21;12:9-19
pubmed: 29317801
J Antimicrob Chemother. 2018 Feb 1;73(suppl_2):ii27-ii35
pubmed: 29490059
J Antimicrob Chemother. 2018 Feb 1;73(suppl_2):ii2-ii10
pubmed: 29490062
J Antimicrob Chemother. 2018 May 1;73(5):1423-1432
pubmed: 29514268
J Antimicrob Chemother. 2018 Nov 1;73(11):3199-3205
pubmed: 30165644
Eur J Clin Pharmacol. 1998 Oct;54(8):653-7
pubmed: 9860154

Auteurs

Victoria Palin (V)

Greater Manchester Connected Health Cities, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester M13 9PL, UK.

Anna Mölter (A)

Greater Manchester Connected Health Cities, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester M13 9PL, UK.

Miguel Belmonte (M)

Greater Manchester Connected Health Cities, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester M13 9PL, UK.

Darren M Ashcroft (DM)

Greater Manchester Connected Health Cities, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester M13 9PL, UK.
NIHR Greater Manchester Patient Safety Translational Research Centre, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester M13 9PL, UK.

Andrew White (A)

NHS Greater Manchester Shared Service, Ellen House, Waddington Street, Oldham OL9 6EE, UK.

William Welfare (W)

Public Health England North West, 3 Piccadilly Place, London Road, Manchester M1 3BN, UK.

Tjeerd van Staa (T)

Greater Manchester Connected Health Cities, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester M13 9PL, UK.
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH